CLASS E SHARE PURCHASE WARRANT NEXIEN BIOPHARMA, INC.Class E Share Purchase Warrant • September 28th, 2018 • Nexien Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS CLASS E SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. Mountain Time on January 31, 2019 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NEXIEN BIOPHARMA, INC., a Delaware corporation (the “Company”), up to ______ shares of Common Stock (the “Warrant Shares”). The purchase price of one Warrant Share shall be equal to the Exercise Price, as defined in Section 1(b).
FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • September 28th, 2018 • Nexien Biopharma, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT is made and entered into this 18th day of September, 2018 (the “Effective Date) between Accu-Break Pharmaceuticals, Inc. (“Licensor”) and Intiva BioPharma Inc. (“Licensee”) (the “Amendment”)
CLASS D UNIT PURCHASE WARRANT NEXIEN BIOPHARMA, INC.Warrant Agreement • September 28th, 2018 • Nexien Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS CLASS D UNIT PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. Mountain Time on November 30, 2018 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NEXIEN BIOPHARMA, INC., a Delaware corporation (the “Company”), up to ______ Units each such Unit consisting of one share of Common Stock (the “Warrant Shares”) and one Class E Common Stock Purchase Warrant (the “Class E Warrants”), which such Class E Warrant shall have an exercise price equal to $2.00 per share and be exercisable through January 31, 2019. The purchase price of one Unit shall be equal to the Exercise Price, as defined in Section 1(b).
